0001725430 EX-FILING FEES 0001725430 2026-01-09 2026-01-09 0001725430 1 2026-01-09 2026-01-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-3
(Form Type)

 

Intelligent Bio Solutions Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

   Security Type  Security Class Title  Fee Calculation or Carry Forward Rule 

Amount

Registered(1)

   Proposed Maximum Offering Price Per Unit(2)     Maximum Aggregate Offering Price    Fee Rate   Amount of Registration Fee(1) 
Newly Registered Securities  
                                       
Fees to Be Paid  Equity  Common Stock, $0.01 par value per share(3)   457(c)   6,896,550   $11.325   $

78,103,428.75

     0.0001381   $10,786.08 
Carry Forward Securities 
Carry Forward Securities                                    — 
   Total Offering Amounts          $ 78,103,428.75          $ 10,786.08 
   Total Fees Previously Paid                      — 
   Total Fee Offsets                      — 
   Net Fee Due                     $ 10,786.08 

 

(1) Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder for the selling stockholders include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
   
(2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Capital Market on January 6, 2026.
   
(3) Consists of 105,000 shares of common stock, 2,193,850 shares of common stock issuable upon exercise of Pre-Funded Warrants, 2,298,850 shares of common stock issuable upon exercise of Series K-1 Warrants and 2,298,850 shares of common stock issuable upon exercise of Series K-2 Warrants, which shares are offered for resale by the selling stockholders named in the prospectus.